AbbVie raised its full-year adjusted earnings guidance and reported higher first-quarter revenue, boosted by growth in its immunology and neuroscience portfolios.
Source link
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
Date:
More like thisRelated
Move 37 Is the Moment AI Changes Everything. It’s Suddenly Happening Everywhere.
A decade ago, a computer did something that no...
2027 NFL draft top pick predictions: Early chances at No. 1
Jordan ReidAug 7, 2026, 06:30 AM ETCloseJordan Reid is...
Progressives win in Michigan, and a pop star announces a break: The news quiz
A rocket collides with the moon, restaurants grapple with...
UNM running back Scottre Humphrey is ready to shine in 2026
ALBUQUERQUE, N.M. (KRQE) – UNM running back Scottre Humphrey said...